In terms of immune phenotypes, ALK+ ALCL tumor cells are primarily characterized by constant CD30 antigen expression in addition to a variety of other immunologic phenotypes (summarized in [5]). The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.